ITC Must Consider Amgen, Roche Dispute Over Mircera

Law360, New York (March 19, 2008, 12:00 AM EDT) -- A federal appeals court has affirmed a ruling allowing Roche Holding AG to import its anemia drug Mircera into the U.S. as long as the company doesn't sell it. But the court disagrees with the International Trade Commission's position that the ITC doesn't have jurisdiction over the case.

The U.S. Court of Appeals for the Federal Circuit issued an order Wednesday sending the case back to the ITC, finding that the commission does have the authority to determine whether Roche's activities in developing and importing the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.